Xiandong Pharmaceutical

HitGen Inc. (SHA: 688222), a China-based company, has announced a strategic partnership with Bostal Drug Delivery Co., Ltd through its subsidiary, Sichuan Xiandong Pharmaceutical Co., Ltd. This alliance is aimed at the research and development (R&D) and manufacturing of nucleic acid drugs, marking a significant step forward in the field…